Malignant fibrous histiocytoma in the craniocervical junction presenting with severe occipitalgia

被引:9
作者
Akai, Takuya
Yamamoto, Kenji
Iida, Takaaki
Iizuka, Hideaki
Nojima, Takayuki
机构
[1] Kanazawa Med Univ, Dept Neurosurg, Kaho Ku, Kanazawa, Ishikawa 9200293, Japan
[2] Kanazawa Med Univ, Dept Pathol, Kanazawa, Ishikawa, Japan
关键词
malignant fibrous histiocytoma; headache; chemotherapy; radiation;
D O I
10.1007/s10014-006-0202-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report a patient who complained of severe occipitalgia caused by destruction of the atlantooccipital joint by tumor invasion. Her symptoms were relieved by tumor resection and occipitocervical fixation. Histological examination of the resected tumor revealed that the tumor cells had an irregular arrangement, remarkable atypia, and pleomorphism with multinucleated bizarre giant cells. The tumor demonstrated no definitive sarcoma differentiation and was identified as malignant fibrous histiocytoma. After tumor resection, the patient received adjuvant radiation and chemotherapy. The tumor regrew outside the radiation field. Chemotherapy with ifosfamide, cisplatin, and etoposide caused remarkable tumor reduction, but suspension of chemotherapy resulted in tumor recurrence. The results of our drug protocol suggest that this regimen is feasible as postoperative adjuvant chemotherapy for malignant fibrous histiocytoma. The role of adjuvant chemotherapy and radiation therapy for this highly malignant rare tumor should be evaluated in a prospective study with precise histological diagnosis.
引用
收藏
页码:101 / 105
页数:5
相关论文
共 34 条
[21]  
Kozuka T, 2002, ANTICANCER RES, V22, P2939
[22]  
OBRIEN JE, 1964, CANCER, V17, P1445, DOI 10.1002/1097-0142(196411)17:11<1445::AID-CNCR2820171112>3.0.CO
[23]  
2-G
[24]   Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts [J].
Oda, Y ;
Tamiya, S ;
Oshiro, Y ;
Hachitanda, Y ;
Kinukawa, N ;
Iwamoto, Y ;
Tsuneyoshi, M .
PATHOLOGY INTERNATIONAL, 2002, 52 (09) :595-606
[25]   Neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone and in osteosarcoma located in the extremities: Analogies and differences between the two tumors [J].
Picci, P ;
Bacci, G ;
Ferrari, S ;
Mercuri, M .
ANNALS OF ONCOLOGY, 1997, 8 (11) :1107-1115
[26]   A phase II study of dose-intense ifosfamide plus epirubicin with hematopoietic growth factors for the treatment of patients with advanced soft tissue sarcomas; a novel sequential schedule [J].
Serrone, L ;
Zeuli, M ;
Gamucci, T ;
Nardi, M ;
Cognetti, F .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 47 (03) :206-210
[27]   Management of craniovertebral junction tuberculosis [J].
Shukla, D ;
Mongia, S ;
Devi, I ;
Chandramouli, BA ;
Das, BS .
SURGICAL NEUROLOGY, 2005, 63 (02) :101-106
[28]   Occipitocervical reconstruction with the Ohio Medical Instruments Loop: results of a multicenter evaluation in 30 cases [J].
Singh, SK ;
Rickards, L ;
Apfelbaum, RI ;
Hurlbert, RJ ;
Maiman, D ;
Fehlings, MG .
JOURNAL OF NEUROSURGERY, 2003, 98 (03) :239-246
[29]   Treatment of Down syndrome-associated craniovertebral junction abnormalities [J].
Taggard, DA ;
Menezes, AH ;
Ryken, TC .
JOURNAL OF NEUROSURGERY, 2000, 93 (02) :205-213
[30]  
Tierney JF, 1997, LANCET, V350, P1647